Comparison (IMAGE)

Society of Nuclear Medicine and Molecular Imaging

Comparison

Caption

This is a comparison of Tc-99m tilmanocept radiopharmaceutical uptake on planar imaging in subjects with active RA (A: 200 μg tilmanocept / 10 mCi Tc-99m; B-C: 400 μg tilmanocept / 10 mCi Tc 99m) versus healthy controls (D-F: 400 μg tilmanocept / 10 mCi Tc-99m) at three hours post-IV administration).

Credit

Credit: A Kardan et al., University Hospitals/Case Western Reserve University, Cleveland, OH

Usage Restrictions

None

License

Licensed content

Disclaimer: AAAS and EurekAlert! are not responsible for the accuracy of news releases posted to EurekAlert! by contributing institutions or for the use of any information through the EurekAlert system.